Ctf Capital Management, LP Verona Pharma PLC Transaction History
Ctf Capital Management, LP
- $135 Million
- Q4 2024
A detailed history of Ctf Capital Management, LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Ctf Capital Management, LP holds 236,773 shares of VRNA stock, worth $14.6 Million. This represents 8.17% of its overall portfolio holdings.
Number of Shares
236,773Holding current value
$14.6 Million% of portfolio
8.17%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
189Shares Held
68.6MCall Options Held
746KPut Options Held
687K-
Perceptive Advisors LLC New York, NY6.32MShares$390 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$344 Million18.53% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$309 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$260 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$209 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.76B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...